Zeniplatin

CAS: 111490-36-9

Ref. 3D-FZ37577

Produktinformation

• Name: Zeniplatin
• Synonyme: Zeniplatin [USAN:INN], Cl 286558, Platinum, (2,2-bis(aminomethyl)-1,3-propanediol-N,N')(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)-, Unii-40Zq0A17It, Zeniplatine, Zeniplatine [INN-French], Zeniplatino, Zeniplatino [INN-Spanish], Zeniplatinum, Zeniplatinum [INN-Latin], cis-(2,2-Bis(aminomethyl)-1,3-propanediol)(1,1-cyclobutanedicarboxylato)platinum, 2,2-Bis(Aminomethyl)Propane-1,3-Diol, Cyclobutane-1,1-Dicarboxylic Acid, Platinum

Beschreibung

Zeniplatin is a platinum-based chemotherapy drug that is used to treat metastatic colorectal cancer. It has been shown to have neurotrophic effects and can increase the production of neurotrophic factors in human serum, which may reduce the severity of bowel disease and inflammatory bowel disease. Zeniplatin has also been shown to be toxic to solid tumours, although it has not yet been tested on humans. The most common side effects are nausea, vomiting, diarrhoea, and anaemia. Zeniplatin is not known to have any drug interactions or carcinogenic potential.

• Marke: Biosynth

Chemische Eigenschaften

• Reinheit: Min. 95%